The Valley Desk

PreprintSSRNPublished

Recombinant Human C1 Esterase Inhibitor Treatment in Addition to Standard of Care for the Prevention of Cytokine Storm in Hospitalized Patients with COVID-19: A Randomized, Open-Label Trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Virtua Health. Affiliation source

Institution
Virtua Health

Publication record

Type
Preprint
Venue
SSRN
Published
Added to directory
Source checked

Report a correction or request removal